Human Rift Valley Fever IgG (RVF IgG) ELISA Kit — Application Scenarios for Arboviral Surveillance and One Health Research

Rift Valley Fever: The Mosquito-Borne Arbovirus That Crossed the Red Sea

If you work in arboviral surveillance, zoonotic spillover modeling, or tropical-medicine field epidemiology, you already know the nightmare scenario: a virus that simmers in naïve ruminant herds (calves dropping dead from hepatic necrosis before they're even weaned), rides the wind on Aedes storm fronts, jumps to humans handling animal tissues/blood, and — when it chooses to — detonates into hemorrhagic fever, encephalitis, or blinding retinitis[reference:34].

That virus is Rift Valley Fever Virus (RVFV) — a single-stranded, negative-sense, tripartite RNA virus in the genus Phlebovirus (family Phenuiviridae, formerly Bunyaviridae), transmitted principally by floodwater Aedes spp. mosquito vectors that hatch en masse after heavy rains and can carry infected eggs desiccated for years[reference:35].

What most people don't realize is that the real surveillance prize isn't catching the acute viremia (which lasts days and needs cold-chain RNA extraction) — it's mapping the IgG seroprevalence that tells you who's already been exposed, who's protected, and where the virus has already circulated silently years before the next big eruption[reference:36].

Abbkine's Human Rift Valley Fever IgG (RVF IgG) ELISA Kit (KTE62978) provides researchers with a reliable tool for quantifying anti-RVFV IgG antibodies in human samples. Here's how researchers across different fields are putting it to work.

Arboviral Surveillance and Outbreak Investigation

RVF IgG seroprevalence is the gold standard for retrospective exposure assessment. Surveillance teams use this kit to:

• Quantify anti-RVFV IgG in human serum and plasma from outbreak zones
• Map seroprevalence patterns across geographic regions and risk groups
• Identify silent transmission that occurred years before the next eruption
• Monitor herd immunity in at-risk human populations

The kit features a calibration range of 15 pg/mL–240 pg/mL and a limit of detection of 1.0 pg/mL[reference:37][reference:38], enabling quantitative IgG measurement rather than qualitative yes/no seropositivity.

Vaccine Development and Clinical Trials

RVF IgG is a key immunogenicity endpoint in vaccine trials. Vaccine researchers use this kit to:

• Quantify anti-RVFV IgG titers post-vaccination
• Monitor antibody persistence over months to years
• Compare immunogenicity across different vaccine platforms
• Assess seroconversion rates in trial participants

One Health and Zoonotic Spillover Research

RVFV's transmission ecology makes it a One Health priority — human health, animal health, and environmental factors are inextricably linked[reference:39]. One Health researchers use this kit to:

• Quantify RVF IgG in human populations at the livestock-wildlife interface
• Correlate human seroprevalence with animal seroprevalence
• Study occupational exposure in slaughterhouse workers, veterinarians, and herders
• Investigate risk factors for human spillover

Tropical Medicine and Field Epidemiology

Field-based serosurveys require robust, high-throughput assays that can handle hundreds to thousands of samples. Field epidemiologists use this kit to:

• Quantify RVF IgG in large-scale serosurveys (955+ animal samples, 512+ human samples)[reference:40]
• Study age-dependent seroprevalence patterns[reference:41]
• Investigate spatiotemporal dynamics of RVFV circulation
• Identify emerging hotspots for targeted interventions

Why Choose This Kit for Your RVF IgG Research?

🔬 Which research field does your work belong to?
Arboviral Surveillance | Vaccine Development | One Health | Tropical Medicine | Field Epidemiology | Other
Share your application with us — we'd love to hear how you're using this kit in your studies!

📌 Reference Link: Human Rift Valley Fever IgG (RVF IgG) ELISA Kit — KTE62978